While we have investigated the correlation between CAHM methylation and disease stage, we have not looked for correlations with cancer subtypes (e.g., deficienct MLH1 DNA mismatch repair and microsatellite instability; CIMP status and associated BRAF mutations; and the presence of other classic PI3K/MAPK or Wnt pathway mutations). Here, MLH1 is linked to cancer.